Not much happening right now on the clinical front. I imagine there will be some fireworks on tomorrow's conference call, though. Management is probably not looking forward to some of the questions (SEC investigation, 483 issue, trial enrollment, pipeline, etc).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.